Autoimmunity

Revised 2017 international consensus on ANCA testing in small vessel vasculitis: support from an external quality assessment
Sylvia Broeders, Sylvie Goletti, Jean-Paul Tomasi, Carolien Bonroy, René-Louis Humbel, Laurence Lutteri, Sofie Schouwers, Lieve Van Hoovels, Martine Vercammen, Xavier Bossuyt

Annals of the Rheumatic Diseases Oct 2019, 78 (10) e113; DOI: 10.1136/annrheumdis-2018-214078
Correspondence to ‘Standardisation of myositis-specific antibodies: where are we today?’ by Mahler et al
Maria Infantino, Mariangela Manfredi, Nicola Bizzaro

Annals of the Rheumatic Diseases Sep 2019, annrheumdis-2019-216217; DOI: 10.1136/annrheumdis-2019-216217
Association of Epstein-Barr virus serological reactivation with transitioning to systemic lupus erythematosus in at-risk individuals
Neelakshi R Jog, Kendra A Young, Melissa E Munroe, Michael T Harmon, Joel M Guthridge, Jennifer A Kelly, Diane L Kamen, Gary S Gilkeson, Michael H Weisman, David R Karp, Patrick M Gaffney, John B Harley, Daniel J Wallace, Jill M Norris, Judith A James

Annals of the Rheumatic Diseases Sep 2019, 78 (9) 1235-1241; DOI: 10.1136/annrheumdis-2019-215361
Response to: ‘Checkpoint inhibitors and arthritis: seeking balance between victories and defeats’ by Moura and Moura
Thierry Schaeverbeke, Marie Kostine

Annals of the Rheumatic Diseases Sep 2019, 78 (9) e92; DOI: 10.1136/annrheumdis-2018-213906
Combined genetic and transcriptome analysis of patients with SLE: distinct, targetable signatures for susceptibility and severity
Nikolaos I Panousis, George K Bertsias, Halit Ongen, Irini Gergianaki, Maria G Tektonidou, Maria Trachana, Luciana Romano-Palumbo, Deborah Bielser, Cedric Howald, Cristina Pamfil, Antonis Fanouriakis, Despoina Kosmara, Argyro Repa, Prodromos Sidiropoulos, Emmanouil T Dermitzakis, Dimitrios T Boumpas

Annals of the Rheumatic Diseases Aug 2019, 78 (8) 1079-1089; DOI: 10.1136/annrheumdis-2018-214379
Anti-Ku syndrome with elevated CK and anti-Ku syndrome with anti-dsDNA are two distinct entities with different outcomes
Lionel Spielmann, Benoit Nespola, François Séverac, Emmanuel Andres, Romain Kessler, Aurélien Guffroy, Vincent Poindron, Thierry Martin, Bernard Geny, Jean Sibilia, Alain Meyer

Annals of the Rheumatic Diseases Aug 2019, 78 (8) 1101-1106; DOI: 10.1136/annrheumdis-2018-214439
Response to: ‘Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) induced by immune checkpoint inhibitors’ by Delyon et al
Marie Kostine, Thierry Schaeverbeke

Annals of the Rheumatic Diseases Aug 2019, 78 (8) e83; DOI: 10.1136/annrheumdis-2018-213895
Changing the wolf from outside: how microbiota trigger systemic lupus erythematosus
Isabelle Peene, Dirk Elewaut

Annals of the Rheumatic Diseases Jul 2019, 78 (7) 867-869; DOI: 10.1136/annrheumdis-2019-215221
Drug-induced lupus erythematosus following immunotherapy with anti-programmed death-(ligand) 1
Jean-Marie Michot, Mathilde Fusellier, Stephane Champiat, Charles Velter, Capucine Baldini, Anne-Laure Voisin, Francois-Xavier Danlos, Yolla El Dakdouki, Maxime Annereau, Xavier Mariette, Caroline Robert, Khadija Cherif, Aurélien Marabelle, Christine Mateus, Olivier Lambotte

Annals of the Rheumatic Diseases Jul 2019, 78 (7) e67; DOI: 10.1136/annrheumdis-2018-213677
Checkpoint inhibitor-induced polymyalgia rheumatica controlled by cobimetinib, a MEK 1/2 inhibitor
Karmela Kim Chan, Anne R Bass

Annals of the Rheumatic Diseases Jul 2019, 78 (7) e70; DOI: 10.1136/annrheumdis-2018-213672

Main menu

Autoimmunity

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Autoimmunity

Pages